Back to catalogue
№ 192 25 filings · 2021-09-13 → 2026-07-28

GAMING REALMS PLC

GMR
Consumer Products and Services Share price 29.50p Market cap £80m Overall fit 400 /1000

High operating leverage, fair valuation and pristine balance sheet fit three of the investor's four criteria well, but the AI-beneficiary angle is essentially absent — this is a mobile-gaming IP licensor, not a picks-and-shovels AI receiver, which caps the fit under the ~35%-weighted AI criterion.

Fair value range 35p–45p Mid case · £108m
Absolute upside +35.7% vs current market cap
Conviction 4/5 confidence in undervalued call
Supports the call
  • Clean unmodified audits and simple, transparent segment disclosure
  • Debt-free balance sheet with £13.5m net cash supports downside case
  • Consistent multi-year delivery vs. own guidance
Limits the call
  • UK Remote Gaming Duty hike impact still playing out through H2 2026
  • Growth clearly decelerating — mid-case multiple depends on international re-acceleration
Methodology

Blended EV/EBITDA and P/E on normalised 2026-27 earnings

In one line · bull case

A debt-free, high-operating-leverage niche gaming content platform available at ~4x EV/EBITDA with underappreciated international growth optionality offsetting UK regulatory drag.

In one line · biggest risk

The combination of a 40% UK Remote Gaming Duty and structural growth deceleration compresses the business into a low-growth cash cow, with the market re-rating it lower rather than higher.

Drivers
AI beneficiary 15 /100
Mobile casino content licensor with proprietary RGS platform but no meaningful AI revenue line, AI-training data asset or agentic AI leverage
Operating leverage 78 /100
48% Adj EBITDA margin with largely fixed staff/platform cost base; incremental licensing revenue drops through at >60% contribution margin
Earnings vs expectations 65 /100
Consistent in-line or modest beat vs own guidance across 5 years, with no profit warnings in the covered period
Growth momentum 55 /100
Revenue growth decelerated from 22% (2024) to 10% (2025) with H1 26 reported revenue slightly down; underlying core still growing ~9%
Moat 55 /100
Slingo hybrid format is a unique, brand-recognised category with growing regulated distribution, but the moat is content IP rather than structural
Earnings quality 70 /100
Clean cash conversion (63% of Adj EBITDA in 2025), unmodified audits, though rising capitalised development (£7.9m in 2025) warrants monitoring
Management quality 70 /100
Experienced team with disciplined capital allocation, buybacks at accretive prices, no dividends while reinvesting; minor governance friction on AGM pre-emption votes
Cyclicality 30 /100
iGaming is relatively defensive but not immune; some sensitivity to consumer discretionary spend and material regulatory-tax cycles (UK RGD)
Leverage 5 /100
Debt-free with £13.5m net cash at H1 26 after £6m buyback — fortress balance sheet
Value-trap signals · 4
  • Revenue growth decelerating meaningfully over three years
  • UK regulatory drag intensifying (staking limits then RGD hike from 21% to 40%)
  • Rising capitalised development spend flattering reported EBITDA vs cash EBITDA
  • Two AGM defeats on pre-emption disapplication (2024, 2026)

Gaming Realms plc (GMR.L) — Research Note

Executive summary

Gaming Realms develops and licenses proprietary "Slingo" mobile casino content (a hybrid slots/bingo format) plus adjacent slot games to regulated iGaming operators globally, with a small tail of B2C social publishing in the US. The Group has compounded content-licensing revenue at ~34% CAGR since 2019 (£3.1m → £27.6m), lifting Adjusted EBITDA margin from breakeven to 48% and generating strong cash while remaining debt-free with a £13.5m cash pile 2026-03-30 annual results; 2026-07-28 H1 pre-close. The single most important point today is that the current 30p price bakes in a two-headed worry — UK Remote Gaming Duty doubling to 40% from April 2026 and decelerating group growth — while the North American and rest-of-world content engine continues to compound at double-digits with high operating leverage.

Fair value estimate

  • Fair value range: 35p – 45p (implied mcap £94m – £121m; mid ~£108m)
  • Methodology: Blended EV/EBITDA multiple + P/E cross-check.
    • 2026E Adjusted EBITDA of £14–16m (H1 26 £6.6m annualised, adjusting for c.£1.5m share-based charges and continuing UK RGD pressure offset by AB/international launches). Applied 6.0–7.5x EV/EBITDA (gaming-content peer range) → EV £84–120m. Add H1 26 net cash £13.5m → equity £97–133m, i.e. 36–49p.
    • P/E cross-check: 2025 diluted EPS 1.91p depressed by full corporation-tax charge kicking in (2024 EPS 2.87p benefitted from deferred-tax credit). Normalised EPS ~2.5–3.0p at 13–15x = 33–45p.
  • Vs. current £79.6m mcap (30p): mid-case upside ~+33% (range +17% to +50%).

Sector context

  • Sector classification confirmed: Consumer Discretionary / Consumer Products & Services (though functionally this is B2B gaming software/IP licensing rather than a consumer discretionary name).
  • Quality/growth/leverage profile is above typical AIM consumer peers: debt-free balance sheet, 48% Adjusted EBITDA margin, 63% cash conversion, buying back stock.
  • Listed comparables: Playtech (PTEC.L), Evolution (EVO.ST), Light & Wonder (LNW). Peer multiples typically 6–10x EV/EBITDA depending on growth/regulation exposure; GMR trades at c.4.1x EV/Adj EBITDA — clearly a discount.

Investment thesis

  • Operating leverage on a genuinely scaling content platform: Revenue grew from £14.7m (2021) to £31.4m (2025); Adj EBITDA margin expanded from 39% to 48% 2026-03-30 annual results. Content licensing carries EBITDA margins >60% at the segment level.
  • International runway is real and diversifying away from UK regulatory drag: Now in 33 regulated markets; North America 63% of content licensing revenue with recent adds Alberta (post H1 26), Delaware, plus Peru/Nigeria/Ghana/Kenya in Q1 26 2026-07-28 H1 pre-close; 2026-03-30 annual results. UK is only 23% of group revenue.
  • Quality balance sheet supports capital returns at a valuation trough: £17.8m year-end cash, no debt, £6m buyback completed in H1 26 and further £5m announced 2026-03-30 annual results; 2026-07-28 H1 pre-close. Buybacks executed at 30–42p — accretive at current prices.

Key risks

  • UK Remote Gaming Duty doubling from 21% → 40% (April 2026) is a live headwind; UK gross gaming revenue has recovered but this compresses partner economics 2026-07-28 H1 pre-close.
  • Growth deceleration: H1 2026 reported revenue £15.5m vs £16.0m H1 25 (though underlying core +9% ex a one-off brand renewal); Adj EBITDA declined y/y — the narrative of "16% underlying" needs to prove out 2026-07-28 H1 pre-close.
  • Concentration on one IP ("Slingo"): The moat is a hybrid game format; competitor content and evolving player tastes could erode share. Also concentration risk in North America — dependent on continued state-level iGaming regulation, which is slow-moving.

Operating leverage

Very high. In 2025, licensing revenue rose 13% but licensing-segment EBITDA rose ~15% and margin expanded 2026-03-30 annual results, segment table. Fixed costs are dominated by headcount (development/platform teams) and central admin (£2.7m); revenue-linked operating expenses were only £6.3m against £31.4m revenue, so gross-margin proxy is ~80%. Head-office costs (£2.7m) barely moved from £2.6m despite 10% revenue growth. If revenue beats current run-rate by 10–20% (e.g. faster US-state regulation or Alberta ramp), the incremental revenue would earn contribution margins likely >70% at the licensing segment, potentially adding 40–60% to Adjusted EBITDA. A £3–4m revenue upside beat could translate to a £2–3m EBITDA uplift — that's 15–20% of current EBITDA. The RGS platform itself is capacity-elastic (processed £7.4bn transactions in 2025) 2026-03-30 annual results, Chairman's statement.

Value-trap signals

  • Growth clearly decelerating (revenue +22% in 2024, +10% in 2025, flat/slightly down reported H1 26).
  • UK regulatory environment persistently deteriorating (staking limits 2025, RGD hike 2026).
  • Increasing capitalised development costs (£7.9m in 2025 vs £5.4m in 2024) — worth watching if revenue growth doesn't reaccelerate, since this flatters EBITDA.
  • AGM defeats on pre-emption rights (2024 and 2026) show some governance friction with shareholders.
  • Related-party transactions (Buckley consultancy, Jim Ryan/Boyd Interactive licence fees) exist but are small and disclosed.

Earnings vs. expectations

The Group has generally beaten or met management guidance across the covered period, with several "in line with market expectations" pre-close updates: FY22 (rev +27%, EBITDA +36%), FY23 (rev +23%, EBITDA +28%), FY24 (rev +22%, EBITDA +30%), FY25 (rev +10%, EBITDA +15% — meeting expectations). H1 26 pre-close guided to "on track to meet full year market expectations" despite optically softer numbers due to a prior-period brand licensing renewal 2026-07-28 H1 pre-close. Pattern: consistent delivery vs. own guidance, with the beats becoming smaller as growth matures. No profit warnings in the covered period.

Conviction

Conviction: 4 (high).

  • Anchoring factors: Clean, unmodified audit opinions across 5 years; simple business model with clear segment disclosure; consistent management track record; debt-free balance sheet removes tail-risk in valuation.
  • Limiting factors: (1) UK RGD impact is still playing out — H2 2026 numbers matter; (2) growth trajectory is genuinely decelerating and needs re-acceleration from international/North American launches to defend the mid-case multiple.

Filings consulted · 28

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-07-28H1 2026 Pre Close Trading Update2026-07-28_9689851_h1-2026-pre-close-trading-update.md0.85
  2. 2026-06-11Result OF Agm2026-06-11_9614536_result-of-agm.md0.30
  3. 2026-03-31Investor Presentation2026-03-31_9499274_investor-presentation.md0.70
  4. 2026-03-30Annual Results 20252026-03-30_9496977_annual-results-2025.md1.00
  5. 2026-02-10Fy25 Pre Close Trading Update2026-02-10_9422475_fy25-pre-close-trading-update.md0.72
  6. 2025-09-08Interim Results2025-09-08_9092093_interim-results.md0.77
  7. 2025-07-29Pre Close Trading Update2025-07-29_9007927_pre-close-trading-update.md0.55
  8. 2025-06-04Result OF Agm2025-06-04_8912742_result-of-agm.md0.20
  9. 2025-03-31Annual Results 20242025-03-31_8804052_annual-results-2024.md0.65
  10. 2025-02-04Fy24 Pre Close Trading Update2025-02-04_8719560_fy24-pre-close-trading-update.md0.55
  11. 2024-09-11Interim Results2024-09-11_8409815_interim-results.md0.58
  12. 2024-07-30Pre Close Trading Update2024-07-30_8337047_pre-close-trading-update.md0.38
  13. 2024-06-14Result OF Agm2024-06-14_8260520_result-of-agm.md0.14
  14. 2024-04-02Investor Presentation2024-04-02_8114818_investor-presentation.md0.32
  15. 2024-04-02Annual Results 20232024-04-02_8114490_annual-results-2023.md0.45
  16. 2024-02-05Pre Close Trading Update2024-02-05_8020748_pre-close-trading-update.md0.38
  17. 2023-09-28Investor Presentation2023-09-28_7782698_investor-presentation.md0.32
  18. 2023-09-12Interim Results2023-09-12_7749038_interim-results.md0.41
  19. 2023-07-27Pre Close Trading Update2023-07-27_7657717_pre-close-trading-update.md0.21
  20. 2023-05-31Result OF Agm2023-05-31_7552930_result-of-agm.md0.07
  21. 2023-04-03Annual Results 20222023-04-03_7424165_annual-results-2022.md0.25
  22. 2023-02-01Pre Close Trading Update And Board Changes2023-02-01_7290756_pre-close-trading-update-and-board-changes.md0.21
  23. 2022-09-20Interim Results2022-09-20_7369308_interim-results.md0.23
  24. 2022-06-08Result OF Agm2022-06-08_6870043_result-of-agm.md0.07
  25. 2022-04-26Annual Results 20212022-04-26_7041715_annual-results-2021.md0.25
  26. 2022-01-26Pre Close Trading Update2022-01-26_6952991_pre-close-trading-update.md0.21
  27. 2021-11-02Full Igaming Licence IN Michigan Amp Trading Update2021-11-02_6626393_full-igaming-licence-in-michigan-amp-trading-update.md0.21
  28. 2021-09-13Interim Results2021-09-13_6823619_interim-results.md0.23

This research note was authored by a large language model after reading 25 regulatory filings published between 2021-09-13 and 2026-07-28. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.